CD8A and neoplasm: A recent study illustrated the percentage of IFN-γ producing CD8+ T cells increased following anti-Tim-3 treatment to MC38 tumor bearing C57B6 mice, suggesting the enhancement of CD8+ T cell function in TME (80).